Ascellux Email Formats

Biotechnology Research • • 1-10 Employees

Key Contact at Ascellux

Duane Grant

Chief Executive Officer/Research Project Manager

Company overview

Headquarters	XX
NAICS	541714
Founded	2019
Employees	1-10

About Ascellux

We intend to change the landscape of healthcare through our nanotechnology! The first way we intend to do this is via our novel theranostic oncology solution known as deep photoimmunotherapy (DEPIT). It's a high efficacy alternative to radiotherapy & chemotherapy targeting deep cancerous growths, with none of the nasty associated side effects of the typical aforementioned treatments. In its simplest form, DEPIT's method of action is a magnetic activation, releasing a modular, targeted payload alongside reactive oxygen species to eliminate cancer cells with high specificity; on top of this, targeting and imaging compounds are also integrated into the treatment structure, allowing wide-spectrum diagnosis and visualization. Feel free to reach out regarding strategic partnership or employment opportunities. We are proud members of JLAB's innovation portfolio! (Johnson & Johnson Innovation Northeast)

Employees by Management Level

Total employees: 1-10

Seniority

Employees

C-Suite

Employees by Department

Ascellux has 1 employees across 1 departments.

Departments

Number of employees

Funding Data

Ascellux has never raised funding before.

Frequently asked questions

Ascellux is located in XX.

Ascellux was founded in 2019, making it 7 years old. The company has established itself as a significant player in its industry over this time.

Ascellux has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.

Key Contact at Ascellux

Duane Grant

Chief Executive Officer/Research Project Manager

4.8

40,000 users